GMED is one of the 6 Notified Bodies to have been recognized as a European Notified Body partner in the framework of the 3rd version of the Technical Cooperation Programme (TCP III), established by the TFDA (Taiwan Food and Drug Administration).

TCP III allows European manufacturers to submit ISO 13485 audit reports issued by European Union Notified Bodies designated under Regulations (EU) 2017/745 and (EU) 2017/746 and recognized as partners, for consideration by TFDA-authorized medical device Quality Management System audit bodies.

As a partner of the Technical Cooperation Program (TCP) for several years, GMED has been accompanying manufacturers and thus facilitating the access of their products to Taiwan.




Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...

Learn more